首页> 美国卫生研究院文献>Genetics >Cryptic Operon for β-Glucoside Metabolism in ESCHERICHIA COLI K12: Genetic Evidence for a Regulatory Protein
【2h】

Cryptic Operon for β-Glucoside Metabolism in ESCHERICHIA COLI K12: Genetic Evidence for a Regulatory Protein

机译:ESCHERICHIA COLI K12中β-糖苷代谢的隐性操纵子:调控蛋白的遗传证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Escherichia coli K12 does not metabolize β-glucosides such as arbutin and salicin because of lack of expression of the bglBSRC operon, which contains structural genes for transport (bglC) and hydrolysis (bglB) of phospho-β-glucosides. Mutants carrying lesions in the cis-acting regulatory site bglR metabolize β-glucosides as a consequence of expression of this cryptic operon (Prasad and Schaefler 1974). We isolated mutations promoting β-glucoside metabolism that were unlinked to bglR; some of these mutations were shown to be amber. All of them were mapped at 27 min on the E. coli K12 linkage map and appeared to define a single gene, for which we propose the designation bglY. Utilization of β-glucosides in bglY mutants appeared to be a consequence of expression of the bglBSRC operon, since bglB bglR and bglB bglY double mutants had the same phenotype. All bglY mutations analyzed were recessive to the wild-type bglY+ allele. Phospho-β-glucosidase B and β-glucoside transport activities are inducible in bglY mutants, as they are in bglR mutants. Metabolism of β-glucosides in both bglR and bglY mutants required cyclic AMP. We propose that bglY encodes a protein acting as a repressor of the bglBSRC operon, active in both the presence and absence of β-glucosides, whose recognition site would be within the bglR locus.
机译:由于缺乏表达bglBSRC操纵子的bglBSRC操纵子的表达,大肠杆菌K12不会代谢β-葡萄糖苷,例如熊果苷和水杨素,bglBSRC操纵子包含磷酸-β-葡萄糖苷的转运(bglC)和水解(bglB)的结构基因。由于这种隐性操纵子的表达,在顺式作用调节位点bglR中携带病变的突变体代谢了β-葡萄糖苷(Prasad and Schaefler 1974)。我们分离了与bglR无关的促进β-葡萄糖苷代谢的突变;其中一些突变显示为琥珀色。所有这些都在27分钟时在大肠杆菌K12连锁图上作图,似乎定义了一个基因,为此我们建议将其命名为bglY。由于bglB bglR和bglB bglY双重突变体具有相同的表型,因此在bglY突变体中使用β-糖苷似乎是bglBSRC操纵子表达的结果。分析的所有bglY突变均对野生型bglY + 等位基因具有隐性。 bglY突变体和 bglR 突变体中都可以诱导磷酸化-β-葡萄糖苷酶B和β-葡萄糖苷转运活性。在 bglR bglY 突变体中,β-葡萄糖苷的代谢都需要环状AMP。我们建议 bglY 编码一种蛋白,作为 bglBSRC 操纵子的阻遏物,在存在和不存在β-葡萄糖苷的情况下均具有活性,其识别位点位于< em> bglR 位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号